JP Patent

JP7125526B2 — 局所用組成物及びこれを使用する方法

Assigned to ノヴァン，インコーポレイテッド · Expires 2022-08-24 · 4y expired

What this patent protects

Patent listed against berdazimer-sodium.

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

Patent Metadata

Patent number: JP7125526B2
Jurisdiction: JP
Classification: —
Expires: 2022-08-24
Drug substance claim: No
Drug product claim: No
Assignee: ノヴァン，インコーポレイテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.